Draft Evidence Report
CTAF

This is not the most recent version of this material.
For an updated version, please see the relevant topic page.

Treatments for Hepatitis C: Intial Draft Report

A draft report reviewing the comparative clinical effectiveness and value of Sofosbuvir (Sovaldi®, Gilead Sciences, Inc.) and Simeprevir (Olysio®, Janssen Products, LP). This draft report was updated based on public comments received.

View All Materials on this Topic or Go Back to View More Materials